Methadone treatment of injecting opioid users for prevention of HIV infection

Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL (2006)
JOURNAL OF GENERAL INTERNAL MEDICINE 21(2): 193-195.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ;
Abstract / Bemerkung
OBJECTIVE: To assess the effects of oral substitution treatment for opioid-dependent injecting drug users on HIV risk behaviors and infections. DATA SOURCES: Multiple electronic databases were searched. Reference lists of retrieved articles were checked. METHODS: Because of varying methodologies of available studies, this systematic review was limited to a descriptive summary, looking at consistency of outcomes across studies. RESULTS: Twenty-eight studies involving methadone treatment were included in the review. Methadone maintenance treatment is associated with statistically significant reductions in injecting use and sharing of injecting equipment. It is also associated with reductions in numbers of injecting drug users reporting multiple sex partners or exchanges of sex for drugs or money, but has little effect on condom use. It appears that the reductions in risk behaviors do translate into fewer cases of HIV infection. CONCLUSIONS: Methadone maintenance treatment for injecting drug users significantly reduces the risk of transmission of HIV and should be provided as a component of a strategic approach to the prevention and control of HIV infection. There is insufficient evidence to determine whether other forms of oral substitution treatment also reduce the risk of HIV transmission.
Erscheinungsjahr
Zeitschriftentitel
JOURNAL OF GENERAL INTERNAL MEDICINE
Band
21
Zeitschriftennummer
2
Seite
193-195
ISSN
eISSN
PUB-ID

Zitieren

Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL. Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE. 2006;21(2):193-195.
Gowing, L. R., Farrell, M., Bornemann, R., Sullivan, L. E., & Ali, R. L. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE, 21(2), 193-195. doi:10.1111/j.1525-1497.2005.00287.x
Gowing, L. R., Farrell, M., Bornemann, R., Sullivan, L. E., and Ali, R. L. (2006). Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE 21, 193-195.
Gowing, L.R., et al., 2006. Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE, 21(2), p 193-195.
L.R. Gowing, et al., “Methadone treatment of injecting opioid users for prevention of HIV infection”, JOURNAL OF GENERAL INTERNAL MEDICINE, vol. 21, 2006, pp. 193-195.
Gowing, L.R., Farrell, M., Bornemann, R., Sullivan, L.E., Ali, R.L.: Methadone treatment of injecting opioid users for prevention of HIV infection. JOURNAL OF GENERAL INTERNAL MEDICINE. 21, 193-195 (2006).
Gowing, LR, Farrell, M, Bornemann, Reinhard, Sullivan, LE, and Ali, RL. “Methadone treatment of injecting opioid users for prevention of HIV infection”. JOURNAL OF GENERAL INTERNAL MEDICINE 21.2 (2006): 193-195.

42 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

HIV risks and seroprevalence among Mexican American injection drug users in California.
Martinez AN, Bluthenthal RN, Flynn NM, Anderson RL, Kral AH., AIDS Behav 15(1), 2011
PMID: 20020194
The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.
Yang J, Oviedo-Joekes E, Christian KW, Li K, Louie M, Schechter M, Spittal P., Drug Alcohol Rev 30(6), 2011
PMID: 21355933
Can drug users be effective change agents? Yes, but much still needs to change.
Dickson-Gomez J., Subst Use Misuse 45(1-2), 2010
PMID: 20025444
Impact of interim methadone maintenance on HIV risk behaviors.
Wilson ME, Schwartz RP, O'Grady KE, Jaffe JH., J Urban Health 87(4), 2010
PMID: 20386992
Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.
Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, Robertson JR., BMJ 341(), 2010
PMID: 20595255
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study.
Meade CS, Weiss RD, Fitzmaurice GM, Poole SA, Subramaniam GA, Patkar AA, Connery HS, Woody GE., J Acquir Immune Defic Syndr 55(1), 2010
PMID: 20393347
Drug treatment as HIV prevention: expanding treatment options.
Metzger DS, Zhang Y., Curr HIV/AIDS Rep 7(4), 2010
PMID: 20803321
Drug treatment as HIV prevention: a research update.
Metzger DS, Woody GE, O'Brien CP., J Acquir Immune Defic Syndr 55 Suppl 1(), 2010
PMID: 21045597
The effect of methadone maintenance on positive outcomes for opiate injection drug users.
Corsi KF, Lehman WK, Booth RE., J Subst Abuse Treat 37(2), 2009
PMID: 19150202
Opioid dependence treatment: options in pharmacotherapy.
Stotts AL, Dodrill CL, Kosten TR., Expert Opin Pharmacother 10(11), 2009
PMID: 19538000
Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.
Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O'Connor PG, Schottenfeld RS, Fiellin DA., J Subst Abuse Treat 35(1), 2008
PMID: 17933486

29 References

Daten bereitgestellt von Europe PubMed Central.

Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-control study.
Serpelloni G, Carrieri MP, Rezza G, Morganti S, Gomma M, Binkin N., AIDS Care 6(2), 1994
PMID: 8061081
Buprenorphine treatment for opioid dependence: the relative efficacy of daily, twice and thrice weekly dosing.
Marsch LA, Bickel WK, Badger GJ, Jacobs EA., Drug Alcohol Depend 77(2), 2005
PMID: 15664721
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick RP, Breen C, Kimber J, Davoli M., 2002
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Mattick RP, Kimber J, Breen C, Davoli M., Cochrane Database Syst Rev (2), 2003
PMID: 12804429

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 16336624
PubMed | Europe PMC

Suchen in

Google Scholar